Tuesday, June 10, 2014
What's the Ideal PH Treatment?
Whether you participated in the May 13 Food and Drug Administration (FDA) meeting on pulmonary arterial hypertension (PAH) or not, there is still time to make your voice heard!
FDA is seeking written comments until July 14 to the same questions that they posed during that meeting. The questions are about your experience living with PAH. You can answer them all or pick one or two. Bullet points or other informal approaches are welcome.
Please take a few minutes to check out the questions FDA needs answers to and submit your comments. (Scroll half-way down to II. Public Meeting Information. When you're ready, click "submit comments" at the top right.)
Learn more and submit comments